Treatment of Conjunctival Keratoacanthoma with Topical Interferon-alpha2b
Journal of Ophthalmic and Optometric Sciences,
Vol. 2 No. 3 (2018),
23 June 2018
,
Page 35-38
https://doi.org/10.22037/joos.v2i3.29571
Abstract
Conjunctival keratoacanthoma is a rare disease which is believed to be a low-grade form of squamous cell carcinoma (SCC). Although conjunctival keratoacanthoma was primarily described almost 60 years ago, only few cases have been described in the English literature and its diagnosis and treatment guidelines are still controversial. Almost all suggested treatment options have been surgical methods and non-invasive methods have rarely been examined in treatment of this disease. Here we report an interesting case of conjunctival keratoacanthoma which was treated with topical Interferon-alpha2b.
Keywords: Interferon-alpha2b; Keratoacanthoma; Conjunctival neoplams.
How to Cite
References
Beham A, Regauer S, Soyer HP, Beham-Schmid C. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol. 1998;5(5):269-80.
Cohn JE, Caruso Sales HM, Nguyen GH, Spector H, Briskin K. Keratoacanthoma of the Nasal Septum Secondary to Ranibizumab Use. Case Rep Pathol. 2017;2017:8257590.
Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26(3):150-63.
Coupland SE, Heimann H, Kellner U, Bornfeld N, Foerster MH, Lee WR. Keratoacanthoma of the bulbar conjunctiva. The British journal of ophthalmology. Br J Ophthalmol. 1998;82(5):586.586.
Griffiths RW. Keratoacanthoma observed. British journal of plastic surgery. Br J Plast Surg. 2004;57(6):485-501.6.
Oellers P, Karp CL, Shah RR, Winnick M, Matthews J, Dubovy S. Conjunctival keratoacanthoma. Br J Ophthalmol. 2014 Feb;98(2):275-6, 285.
Adler E, Turner JR, Stone DU. Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012. Cornea. 2013;32(12):1558-61.
- Abstract Viewed: 158 times
- PDF Downloaded: 118 times
